Canada G1J 1Z4
Information non disponible
Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015Article de revue
Curr Oncol, 30 (2), 2023.
CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian StudyArticle de revue
Clin Lymphoma Myeloma Leuk, 23 (3), 2023.
In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbiditiesArticle de revue
J Surg Oncol, 117 (7), 2018.
Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breastArticle de revue
J Surg Oncol, 117 (6), 2018.
Survival Rate of Breast Cancer Patients who Participated in Clinicals Trials Versus those who did notArticle de revue
J Clin Trials, 4 , 2014.
Evaluation of eligibility and recruitment in breast cancer clinical trialsArticle de revue
Breast, 23 (4), 2014.
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patientsArticle de revue
Ann Pharmacother, 48 (4), 2014.
Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancerArticle de revue
Support Care Cancer, 21 (7), 2013.
Does breast cancer tumor size really matter that much?Article de revue
Breast, 21 (5), 2012.
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollmentArticle de revue
Clin Trials, 9 (5), 2012.